Other tuberculosis of nervous system
ICD-10 A17.89 is a billable code used to indicate a diagnosis of other tuberculosis of nervous system.
Other tuberculosis of the nervous system refers to forms of tuberculosis that affect the central or peripheral nervous system, excluding the more common forms such as tuberculous meningitis or spinal tuberculosis. This condition can manifest as tuberculomas, which are localized lesions in the brain or spinal cord, or as other atypical presentations. Symptoms may include neurological deficits, seizures, headaches, and altered mental status. Diagnosis typically involves imaging studies such as MRI or CT scans, along with microbiological tests like sputum cultures or PCR for Mycobacterium tuberculosis. Treatment usually consists of a prolonged course of antitubercular medications, often requiring monitoring for drug resistance and side effects. Public health considerations are critical, as tuberculosis is a communicable disease, necessitating contact tracing and isolation procedures for active cases. The management of drug-resistant tuberculosis is particularly challenging and requires specialized treatment regimens.
Detailed clinical notes on symptoms, diagnostic tests, and treatment plans.
Patients presenting with neurological symptoms and a history of tuberculosis exposure.
Need for thorough documentation of drug resistance testing and public health reporting.
Neurological assessments, imaging results, and treatment responses.
Patients with unexplained neurological deficits or seizures with a history of tuberculosis.
Differentiating from other neurological disorders and documenting the impact on daily functioning.
Used to evaluate for tuberculomas or other lesions.
Indication for the scan and findings must be documented.
Neurology and Infectious Disease specialists should ensure imaging correlates with clinical findings.
Used for detailed evaluation of suspected tuberculomas.
Clinical rationale for MRI and results must be included.
Documentation should reflect the need for contrast and any neurological symptoms.
Common symptoms include seizures, headaches, cognitive changes, and focal neurological deficits, which may vary based on the specific area of the nervous system affected.
Diagnosis typically involves imaging studies such as MRI or CT scans, along with microbiological tests like sputum cultures or PCR for Mycobacterium tuberculosis.
Treatment usually consists of a prolonged course of antitubercular medications, often requiring monitoring for drug resistance and side effects.
Public health measures include contact tracing, isolation of active cases, and reporting to health authorities to prevent the spread of the disease.
